SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 124 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,294,767 | -34.7% | 592,963 | +0.5% | 0.00% | – |
| Q2 2023 | $3,515,345 | +121.3% | 589,823 | +21.4% | 0.00% | – |
| Q1 2023 | $1,588,373 | -10.3% | 485,741 | +8.4% | 0.00% | – |
| Q4 2022 | $1,770,208 | -57.6% | 448,154 | -35.6% | 0.00% | -100.0% |
| Q3 2022 | $4,171,000 | -30.0% | 695,385 | -25.0% | 0.00% | 0.0% |
| Q2 2022 | $5,961,000 | -59.6% | 927,023 | -48.1% | 0.00% | -50.0% |
| Q1 2022 | $14,753,000 | +30.4% | 1,785,893 | +144.4% | 0.00% | +100.0% |
| Q4 2021 | $11,313,000 | -44.1% | 730,777 | -18.7% | 0.00% | -66.7% |
| Q3 2021 | $20,235,000 | +19.8% | 898,490 | +4.6% | 0.00% | +50.0% |
| Q2 2021 | $16,894,000 | -38.1% | 859,308 | +5.4% | 0.00% | -50.0% |
| Q1 2021 | $27,295,000 | – | 815,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
| Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
| Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
| Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
| HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
| PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
| Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
| Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |